Kotak Private Equity Group
India’s Licious raises $150m at $1.6bn valuation
India’s Licious, a direct-to-consumer fresh meat and seafood delivery company, has raised a USD 150m round led by Amansa Capital at a valuation of USD 1.6bn.
India pharma: The pills are popping
India’s pharmaceuticals industry is thriving on the macro ills of the day. Private equity is well placed to benefit, but the opportunity set is no secret
Advent buys Indian biopharma player
Advent International has agreed to acquire a controlling position in Bharat Serums and Vaccines, an Indian biopharmaceuticals supplier focused on the women’s health segment.
ADIA to enter India distressed asset space
Abu Dhabi Investment Authority (ADIA) will make an anchor commitment of $500 million to an India special situations fund launched in conjunction with Kotak Private Equity.
Everstone pays $33m for Indian drug firm
The Everstone Group has bought a majority stake in Indian pharmaceutical developer Rubicon Research for INR2.2 billion ($32.9 million), providing an exit for Kotak Private Equity.
Kotak Mahindra Group raises $237m for Indian realty
India’s Kotak Mahindra Group has closed a commitment of INR16 billion ($237 million) from institutional investors for equity investments in realty projects.
Brookfield, Kotak acquire Indian road, power projects
Brookfield Asset Management and Kotak Mahindra’s Core Infrastructure India Fund will buy six road and three power projects from Gammon Infrastructure Projects.
India solar developer gets $33m from Kotak Mahindra, EIB funds
Kotak Mahindra Group and European Investment Bank Group (EIB) have together committed INR2 billion ($32.7 million) to India Solar Energy Firm SolarArise India Projects.
India Value Advisors to invest $179m in Manipal Hospitals
India Value Advisors (IVFA) will commit about INR10 billion ($179 million) to Manipal Hospitals over a three-year period, enabling the healthcare provider to more than double its hospital bed capacity. Part of this increase will come through acquisitions.